The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•5 June 2026•

1 min read

Cognyte Software Emerges as Discounted AI Value Play After Q1 Results

Key Facts

1Cognyte delivered Q1'27 revenue of $105.5M, representing a 10% year-over-year increase.

2CGNT shares trade at a forward FY 2027 P/E of 12.0X, significantly lower than its peer Palantir.

3The company achieved positive adjusted EBITDA and reported solid remaining performance obligations.

As investors increasingly seek reasonably priced entries into the AI sector, Cognyte Software is emerging as a notable value play following its latest financial performance. The company delivered Q1 2027 revenue of $105.5 million, marking a 10% year-over-year increase. Furthermore, Cognyte achieved positive adjusted EBITDA and reported solid remaining performance obligations, signaling robust demand for its AI-driven analytics suite.

This growth highlights a significant valuation disconnect compared to industry peers; CGNT shares currently trade at a forward FY 2027 P/E of 12.0x. This is substantially lower than its primary competitor Palantir (PLTR), which trades at a forward multiple exceeding 80x per market data. Analysts view this as a recovery opportunity, particularly as the company stabilizes its financials following a recent 21% price slump that had previously weighed on investor sentiment.

As of the close on June 5, 2026, market participants are watching for a technical rebound to reclaim previous support levels. Looking ahead, traders should monitor the upcoming ISM Manufacturing PMI and scheduled speeches from Fed officials in early June. These macroeconomic catalysts will likely dictate broader risk appetite for mid-cap technology stocks and influence Cognyte's trajectory in the near term.